Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
194M
-
Number of holders
-
565
-
Total 13F shares, excl. options
-
179M
-
Shares change
-
-4.82M
-
Total reported value, excl. options
-
$9.71B
-
Value change
-
-$264M
-
Put/Call ratio
-
0.65
-
Number of buys
-
291
-
Number of sells
-
-269
-
Price
-
$54.16
Significant Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q3 2025
675 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share as of Q3 2025.
BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) has 565 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 179M shares
of 194M outstanding shares and own 92.65% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (22M shares), VANGUARD GROUP INC (18.6M shares), PRIMECAP MANAGEMENT CO/CA/ (15.2M shares), Dodge & Cox (14.7M shares), STATE STREET CORP (8.76M shares), VIKING GLOBAL INVESTORS LP (8.32M shares), AQR CAPITAL MANAGEMENT LLC (5.93M shares), GEODE CAPITAL MANAGEMENT, LLC (3.54M shares), MILLENNIUM MANAGEMENT LLC (2.63M shares), and Capital Research Global Investors (2.54M shares).
This table shows the top 565 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.